1009153

Karyopharm Therapeutics Inc. — FEI 3012640137

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newton, MA (United States)

Additional Details

Sponsor, Contract Research Organization